Results 241 to 250 of about 105,790 (331)

Engineering combination nanomedicines to overcome cancer resistance. [PDF]

RSC Adv
Singh H, Balusamy SR, Sukweenadhi J, Shrivastav A, Mohanprasanth A, Saravanan M, Mijakovic I, Singh P.   +7 more
europepmc   +1 more source

Pro‐ATO/Allicin Liposomes for Dual‐Pathway Targeting of p53‐Mutant Tumors

Advanced Science, EarlyView.
Schematic illustration of the “pro‐ATO”/allicin liposomal strategy. Liposomal encapsulation improves the stability and bioavailability of both agents while masking allicin's odor. Upon release in the tumor microenvironment, ATO reactivates structural p53 mutants, and allicin inhibits ATR signaling while releasing H2S, collectively inducing synthetic ...
Xiaoling Xu, WeiYi Cheng, Menghang Yang, Li He, WeiYe Ren, JingQuan Chen, LiTing He, Dandan Bao, Zhihong Zhu, Lixin Wang, Qinghua Yao, Ji‐Gang Piao   +11 more
wiley   +1 more source

Nano-Immunotherapy Synergizing Ferroptosis and STING Activation in Metastatic Bladder Cancer. [PDF]

Cyborg Bionic Syst
Huang H, Ye F, Liu T, Hong J, Jiang H, Chen Z, Li Q, Chen W.   +7 more
europepmc   +1 more source

DEVELOPMENT OF CONTROLLED DRUG DELIVERY SYSTEMS OF POLYMERIC NANOMEDICINES ASSOCIATED TO SCAFFOLDS FOR TISSUE REGENERATION.

, 2016
Gabriela De Jesús Rodríguez Escalona
openalex   +1 more source

Trojan Horse Strategy: How Biomimetic Nanomedicine Remodels the Tumor Microenvironment

Advanced Science, EarlyView.
This review focuses on biomimetic nanomedicines for tumor microenvironment (TME) remodeling, covering their diverse biomimetic types, design principles, and mechanisms of immune cell reprogramming and reversal of immunosuppressive microenvironments, with particular emphasis on their application in synergistic immunotherapy.
Wanrong Wang, Siqi Mu, Juan Zhang, Guisong Shan, Xueqian Li, Ran Wang, Tao Guo, Xiaoyan He   +7 more
wiley   +1 more source

Nanomedicine

, 2013
  +13 more sources

Nanomedicine applications for the treatment of Staphylococcus aureus infections. [PDF]

FEMS Microbiol Rev
Yedavally H, van Dijl JM, Salvati A.
europepmc   +1 more source

How Precise are Nanomedicines in Overcoming the Blood–Brain Barrier? A Comprehensive Review of the Literature

Priyadarshini Mohapatra, Mohanraj Gopikrishnan, C. George Priya Doss, Natarajan Chandrasekaran   +3 more
openalex   +2 more sources

Precision‐Engineered Silver Single‐Atom Carbon Dot Nanozymes for Theranostic Management of Acute Kidney Injury

Advanced Science, EarlyView.
Mitochondria‐targeted silver single‐atom carbon dot (T‐AgSA‐CDs) nanozymes enable dual SOD/GPx‐like ROS scavenging, real‐time imaging, and therapeutic effects for acute kidney injury (AKI). Atomically dispersed Ag sites synergize with carbon dots to restore renal redox hemostasis, protect mitochondrial function, mitigate inflammation, facilitate post ...
Tianle Tang, Jun Zhang, Yan Wang, Guoping Chen, Kehui Yuan, Yuan He, Chenchen Li, Sumaira Hanif, Yang Yang, Yanli Wang, Pir Muhammad   +10 more
wiley   +1 more source

Nanomedicines Against Mitochondrial Dysfunction-Induced Metabolic Diseases. [PDF]

Adv Sci (Weinh)
Xu K, Wang L, Lv T, Jin C, Wu Q, Zhou Y, Xu G, Duan Z, Luo K, Yang J.   +9 more
europepmc   +1 more source